Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
India Cancer Patients Seek To Use Courts For Access To Patented Drugs – By Tatum Anderson of IP Watch
Country Watch: Nigeria
The Battle for Erlotinib – High Court Decision Raises a Number of Procedural and Practice Issues
Tussle Over Participation In India Compulsory Licence Hearing – IP Watch By Tatum Anderson
Patent Granted for Raltegravir in India
USPTO finds Gilead’s Tenofovir patents invalid following re-examination request by PUBPAT
Unravelling the Valganciclovir patent question in India
Unravelling the Valganciclovir patent question in India
I-MAK Joins Groups in Filing a Public Interest Amici Brief Supporting New U.S Patent Rules
Raltegravir application still pending in India